Defence: Beyond the Obvious Three
Three ASX defence supply chain companies that do not make the shortlists but sit where spending actually flows, offering between 31-163% upside to fair value.
Thoughts on markets, investing, and equity research.
Three ASX defence supply chain companies that do not make the shortlists but sit where spending actually flows, offering between 31-163% upside to fair value.
Wesfarmers, GYG, and Breville have management credibility of 8.7, 9.0, and 8.1 out of 10. All are 24-27% above fair value. The quality premium has absorbed the margin of safety.
HUB24 has grown to 9.3% platform share and is 57% above our A$42.23 fair value. Magellan has compressed from 63bps to 55bps in fees and is 35% above A$6.13. Insignia is priced at CC Capital scheme value. AMP is at equilibrium earning below its cost of equity.
IAG (8.3/10 credibility) and Suncorp (8.0/10) look worst in reporting season yet both are at or above through-cycle targets. IAG's underlying ex-RACQI margin is 16.3%, its highest on record. Suncorp's UITR of 11.7% came in within the 10-12% target despite A$453m of above-allowance nat-cat losses.
Transurban, Telstra, and APA are executing flawlessly. But with the 10-year bond yield at 4.86%, their yield spreads have collapsed to zero or negative. Quality infrastructure at the wrong price.
Spodumene crashed 87% from US$5,000 to US$672 per tonne. Three ASX lithium companies were fully exposed. Their fates diverged based on one factor: where they sat on the cost curve.
Gold is at record highs above A$6,000/oz. Regis Resources made A$323 million profit. St Barbara made A$1.3 million. The difference is hedge book positioning, balance sheet strength, and jurisdiction.
Five Australian REITs in the same rate environment with valuations spanning a 26% NTA discount to a 171% premium. The market is shifting capital from passive landlords to property platforms, and the gap is widening.
Bendigo Bank trades at a 38% premium to fair value with sub-cost-of-equity returns, an AUSTRAC fine of A$250M-A$800M pending, and credit normalisation about to compress earnings 12-15%. The market assigns 80% transformation probability; we assign 40%.
JB Hi-Fi posted record half-year sales of A$6.09 billion, then January comps dropped to +2-3% from +5-7%. The two-speed consumer and late-cycle policy lag signal broader retail weakness through H2 2026.
Cochlear and Pro Medicus are two of the highest-quality businesses on the ASX, both overvalued by 60%+, and both just reported disappointing H1 results. The comparison isolates the quality premium trap from two different angles.
GQG Partners generates 77% operating margins and is run by a founder who owns 70% and has co-invested US$1B+ alongside clients. The market prices a cyclical trough as structural decline, creating a 47% discount.